Tadalafil (Page 12 of 12)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 68382-896-01 in bottle of 100 tablets

Tadalafil Tablets USP, 2.5 mg

Rx Only

100 tablets

ZYDUS

tadalafil tablets
(click image for full-size original)

NDC 68382-897-01 in bottle of 100 tablets

Tadalafil Tablets USP, 5 mg

Rx Only

100 tablets

ZYDUS

Tadalafil Tablets
(click image for full-size original)

NDC 68382-898-01 in bottle of 100 tablets

Tadalafil Tablets USP, 10 mg

Rx Only

100 tablets

ZYDUS

Tadalafil tablets
(click image for full-size original)

NDC 68382-899-01 in bottle of 100 tablets

Tadalafil Tablets USP, 20 mg

Rx Only

100 tablets

ZYDUS

Tadalafil tablets
(click image for full-size original)
TADALAFIL tadalafil tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68382-896
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TADALAFIL (TADALAFIL) TADALAFIL 2.5 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
HYPROMELLOSES
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
TALC
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color WHITE (WHITE) Score no score
Shape CAPSULE (CAPSULE) Size 6mm
Flavor Imprint Code T;1
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68382-896-06 30 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68382-896-16 90 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68382-896-01 100 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68382-896-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68382-896-10 1000 TABLET, FILM COATED in 1 BOTTLE None
6 NDC:68382-896-99 2 BLISTER PACK in 1 CARTON contains a BLISTER PACK
6 15 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (68382-896-99)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA206693 03/27/2019
TADALAFIL tadalafil tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68382-898
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TADALAFIL (TADALAFIL) TADALAFIL 10 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
FERRIC OXIDE YELLOW
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
HYPROMELLOSES
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
TALC
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color YELLOW (YELLOW) Score no score
Shape CAPSULE (CAPSULE) Size 10mm
Flavor Imprint Code 898
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68382-898-06 30 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68382-898-16 90 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68382-898-01 100 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68382-898-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68382-898-10 1000 TABLET, FILM COATED in 1 BOTTLE None
6 NDC:68382-898-99 2 BLISTER PACK in 1 CARTON contains a BLISTER PACK
6 15 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (68382-898-99)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA206693 03/27/2019
TADALAFIL tadalafil tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68382-899
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TADALAFIL (TADALAFIL) TADALAFIL 20 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
FERRIC OXIDE YELLOW
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
HYPROMELLOSES
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
TALC
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color YELLOW (YELLOW) Score no score
Shape OVAL (OVAL) Size 13mm
Flavor Imprint Code 899
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68382-899-06 30 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68382-899-16 90 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68382-899-01 100 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68382-899-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68382-899-10 1000 TABLET, FILM COATED in 1 BOTTLE None
6 NDC:68382-899-99 2 BLISTER PACK in 1 CARTON contains a BLISTER PACK
6 15 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (68382-899-99)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA206693 03/27/2019
TADALAFIL tadalafil tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68382-897
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TADALAFIL (TADALAFIL) TADALAFIL 5 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
FERRIC OXIDE YELLOW
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
HYPROMELLOSES
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
TALC
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color YELLOW (YELLOW) Score no score
Shape OVAL (OVAL) Size 8mm
Flavor Imprint Code 897
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68382-897-50 10 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68382-897-06 30 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68382-897-16 90 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68382-897-01 100 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68382-897-05 500 TABLET, FILM COATED in 1 BOTTLE None
6 NDC:68382-897-10 1000 TABLET, FILM COATED in 1 BOTTLE None
7 NDC:68382-897-99 2 BLISTER PACK in 1 CARTON contains a BLISTER PACK
7 15 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (68382-897-99)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA206693 03/27/2019
Labeler — Zydus Pharmaceuticals (USA) Inc. (156861945)
Registrant — Zydus Pharmaceuticals (USA) Inc. (156861945)
Establishment
Name Address ID/FEI Operations
Cadila Healthcare Limited 918596198 ANALYSIS (68382-896), ANALYSIS (68382-897), ANALYSIS (68382-898), ANALYSIS (68382-899), MANUFACTURE (68382-896), MANUFACTURE (68382-897), MANUFACTURE (68382-898), MANUFACTURE (68382-899)

Revised: 03/2019 Zydus Pharmaceuticals (USA) Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.